Meridian Ohc Partners, Lp Sells 95,529 Shares of InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Stock

InfuSystem Holdings Inc (NYSEAMERICAN:INFU) Director Meridian Ohc Partners, Lp sold 95,529 shares of the business’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $12.33, for a total transaction of $1,177,872.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Meridian Ohc Partners, Lp also recently made the following trade(s):

  • On Tuesday, June 30th, Meridian Ohc Partners, Lp sold 400,000 shares of InfuSystem stock. The stock was sold at an average price of $11.00, for a total transaction of $4,400,000.00.
  • On Sunday, June 28th, Meridian Ohc Partners, Lp sold 794 shares of InfuSystem stock. The shares were sold at an average price of $12.09, for a total transaction of $9,599.46.

Shares of NYSEAMERICAN INFU opened at $11.90 on Wednesday. InfuSystem Holdings Inc has a 52 week low of $4.28 and a 52 week high of $13.25.

InfuSystem (NYSEAMERICAN:INFU) last issued its earnings results on Thursday, May 14th. The medical instruments supplier reported ($0.02) EPS for the quarter. The company had revenue of $21.55 million during the quarter.

A number of institutional investors have recently added to or reduced their stakes in INFU. Acadian Asset Management LLC boosted its position in InfuSystem by 14.5% in the 4th quarter. Acadian Asset Management LLC now owns 29,683 shares of the medical instruments supplier’s stock worth $253,000 after purchasing an additional 3,755 shares in the last quarter. FMR LLC purchased a new stake in InfuSystem in the 4th quarter worth approximately $675,000. EAM Investors LLC purchased a new position in shares of InfuSystem during the 4th quarter valued at approximately $914,000. Alambic Investment Management L.P. purchased a new position in shares of InfuSystem during the 4th quarter valued at approximately $147,000. Finally, Credit Suisse AG purchased a new position in shares of InfuSystem during the 4th quarter valued at approximately $264,000.

Separately, Lake Street Capital started coverage on shares of InfuSystem in a report on Tuesday, June 9th. They set a “buy” rating and a $17.00 price objective on the stock.

InfuSystem Company Profile

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Further Reading: Straddles

Insider Buying and Selling by Quarter for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.